ישראל - עברית - Ministry of Health

cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl. - טיפות - ferrous as iron iii hydroxide polymaltose compl. 50 mg/ml - iron in other combinations - prevention and treatment of iron deficiency anaemia.

ישראל - עברית - Ministry of Health

a.l. medi-market ltd. - iron iii as iron iii hydroxide sucrose complex - iron iii as iron iii hydroxide sucrose complex 20 mg / 1 ml - saccharated iron oxide

ישראל - עברית - Ministry of Health

novartis israel ltd - eltrombopag as olamine - טבליות מצופות פילם - eltrombopag as olamine 25 mg - eltrombopag - eltrombopag - for the treatment of previously treated patients with chronic idiopathic thrombocytopenic purpura (itp) to increase platelet count and reduce or prevent bleeding.

ישראל - עברית - Ministry of Health

novartis israel ltd - eltrombopag as olamine - טבליות מצופות פילם - eltrombopag as olamine 50 mg - eltrombopag - eltrombopag - for the treatment of previously treated patients with chronic idiopathic thrombocytopenic purpura (itp) to increase platelet count and reduce or prevent bleeding.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - human chorionic gonadotropin - אבקה להכנת תמיסה לזריקה - human chorionic gonadotropin 5000 iu/ml - chorionic gonadotrophin - chorionic gonadotrophin - in the female: ovulation induction in infertility due to anovulation or impaired follicle-ripening. preparation of follicles for puncture in controlled ovarian hyperstimulation programs. luteal phase support. in the male: hypogonadotropic hypogonadism (also cases of idiopathic dysspermias have shown a positive response to gonadotropins). delayed puberty associated with insufficient gonadotropic pituitary function.cryptorchidism not due to anatomical obstruction.

ישראל - עברית - Ministry of Health

cts ltd - iron as sucroferric oxyhydroxide - טבליות לעיסות - iron as sucroferric oxyhydroxide 500 mg - sucroferric oxyhydroxide

ישראל - עברית - Ministry of Health

sanofi israel ltd - iron as iron iii sodium ferric glugonate compl. - solution for injection - iron as iron iii sodium ferric glugonate compl. 62.5 mg / 5 ml - various combinations - various combinations - severe iron deficiency states only when oral administration has been found impossible in cases of gastrointestinal malabsorption which rules out oral iron therapy patients treated by dialysis getting erythropoietin.

ישראל - עברית - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 2000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

ישראל - עברית - Ministry of Health

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 1000 iu / 0.5 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

ישראל - עברית - Ministry of Health

novartis israel ltd - ciclosporin - קפסולות - ciclosporin 50 mg - cyclosporin - cyclosporin - prophylaxis of organ rejection in kidney liver heart allogenic transplants in conjunction with corticosteroids. may also be used in the treatment of chronic rejection in patients previously treated with other immuno-suppressive agents. bone marrow transplantation. endogenous uveitis. severe psoriasis above age 16 that did not respond to other treatment. atopic dermatitis in adults only up to 8 weeks for severe cases in which conventional therapy is ineffective or inappropriate. rheumatoid arthritis: severe cases in which standard treatments are ineffective or inappropriate. nephrotic syndrom type mcd (minimal change disease) in cases where conventional therapy has failed.